Zakeri Bijan, Lu Timothy K
Synthetic Biology Group, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States.
ACS Synth Biol. 2013 Jul 19;2(7):358-72. doi: 10.1021/sb300101g. Epub 2012 Dec 4.
Antibiotic discovery has a storied history. From the discovery of penicillin by Sir Alexander Fleming to the relentless quest for antibiotics by Selman Waksman, the stories have become like folklore used to inspire future generations of scientists. However, recent discovery pipelines have run dry at a time when multidrug-resistant pathogens are on the rise. Nature has proven to be a valuable reservoir of antimicrobial agents, which are primarily produced by modularized biochemical pathways. Such modularization is well suited to remodeling by an interdisciplinary approach that spans science and engineering. Herein, we discuss the biological engineering of small molecules, peptides, and non-traditional antimicrobials and provide an overview of the growing applicability of synthetic biology to antimicrobials discovery.
抗生素的发现有着悠久的历史。从亚历山大·弗莱明爵士发现青霉素,到塞尔曼·瓦克斯曼对抗生素的不懈探索,这些故事已成为激励后世科学家的传奇。然而,在多重耐药病原体不断增加之际,近期的发现渠道却已枯竭。事实证明,自然界是抗菌剂的宝贵来源,这些抗菌剂主要由模块化生化途径产生。这种模块化非常适合通过跨科学与工程的跨学科方法进行重塑。在此,我们讨论小分子、肽和非传统抗菌剂的生物工程,并概述合成生物学在抗菌剂发现中日益增长的适用性。